During the past decade, Gazi University Medical Faculty conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 10 clinical trials were completed, i.e. on average, 19.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 9 clinical trials were completed. i.e. 29% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gazi University Medical Faculty" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Merck Sharp & Dohme LLC" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gazi University Medical Faculty" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Eisai Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Gazi University Medical Faculty" are "Crohn Disease" (7 trials), "Ulcerative Colitis" (3 trials), "Blood Transfusion" (2 trials), "COVID-19" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Gazi University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Gazi University Medical Faculty" are "Drug" (47 trials), "Biological" (7 trials), "Other" (4 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Carboplatin" (5 trials), "Etrasimod" (4 trials), "Pembrolizumab" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gazi University Medical Faculty" are 57 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gazi University Medical Faculty". undefined are not yet recruiting, 17 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Gazi University Medical Faculty, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gazi University Medical Faculty, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".